The recall is specific to Eliquis 5mg Tablets (60-count bottle) Lot# HN0063 with expiration date of September 2019. The two tablet strengths have distinct differences in appearance, which may ...

Results showed that Eliquis 10mg twice daily for one week followed by 5mg twice daily for six months showed effiacy comparable to standard of care in treating DVT/PE patients for the primary ...

Available in 2.5 mg and 5mg tablets, the product comes in multiple package sizes including 60, 180 and 500 btl. [Read more: Apotex launches generic atropine sulfate ophthalmic solution ] ...

Bristol-Myers said on Tuesday that it is voluntarily recalling to the customer level one lot of its Eliquis 5-mg tablets after a patient reported getting a bottle that contained 2.5-mg tablets.

The Food and Drug Administration has approved two applications for the first generics of Bristol-Myers Squibb's Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in ...

“Both the 2.5mg twice-daily regimen of apixaban and the 5mg twice-daily regimen were effective, safe, and simple to use,” they added. Eliquis recently had its indications extended to include the ...

TORONTO — Canadian pharmaceutical manufacturer of generic medicines, Apotex Inc. has launched APO-ApixabanTM tablets and has called it the country’s first generic alternative to Eliquis®.

CHADDS FORD, Pa., Nov. 2, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that the U.S. Food and Drug Administration has approved Felodipine Extended-release Tablets USP, ...

The U.S. government on Tuesday selected the first 10 drugs, including the big-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer , that will be subject to the first-ever Medicare ...